Drugs And Medicines
Kentucky 2023 Regular Session
AN ACT relating to chemical dependency treatment services. [SB-90]
Create a new section of KRS Chapter 222 to require treatment centers licensed as a chemical dependency treatment service to provide transportation services or access to transportation services to residents who wish to leave the program; outline transportation service responsibilities.
Sponsored by: Sen. Jimmy Higdon
To Transportation (h) on 03/10/2023
Spread the world
Gettr Kentucky 2023 Regular Session
AN ACT relating to prescription drugs. [SB-68]
Amend KRS 304.17A-164 to establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with the prescription drugs cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; create a new section of Subtitle 17C of KRS Chapter 304 to apply the cost-sharing and rebate
(continued...)
Sponsored by: Sen. Stephen Meredith
To Banking & Insurance (s) on 02/09/2023
Spread the world
Indiana 2023 Regular Session
Prescription for hormonal contraceptives. [HB-1568]
Prescription for hormonal contraceptives. Allows pharmacists who meet certain requirements to prescribe and dispense hormonal contraceptive patches and self-administered hormonal contraceptives (contraceptives). Establishes requirements for pharmacists who elect to prescribe and dispense contraceptives. Provides that a pharmacist is not required to prescribe a contraceptive to a woman if the pharmacist believes the contraceptive is contraindicated or objects on ethical, moral, or religious grounds. Provides that an individual who is a pharmacy technician,
(continued...)
Sponsored by: Sen. Lonnie Randolph
Public Law 154 on 05/01/2023
Spread the world
Indiana 2023 Regular Session
Drug schedules. [SB-379]
Drug schedules. Adds specified substances to the list of controlled substances. Defines "fentanyl containing substance" and increases the penalty for dealing a drug that is a fentanyl containing substance.
Sponsored by: Sen. Aaron Freeman
Public Law 48 on 04/20/2023
Spread the world
Indiana 2023 Regular Session
Kratom. [HB-1500]
Kratom. Defines "kratom product" as a food product or dietary ingredient that: (1) is derived from the leaf or extract of mitragyna speciosa and has a level of residual solvent that is not more than permitted by USP 467; (2) does not contain a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than 1% of the overall alkaloid composition of the product; and (3) does not contain any synthetic alkaloids including synthetic mitragynin, synthetic 7-hydroxymitragynine, or any other synthetic compound of a kratom plant. Establishes
(continued...)
Sponsored by: Sen. Jon Ford
First Reading: Referred To Committee On Commerce And Technology on 03/06/2023
Spread the world
Indiana 2023 Regular Session
Audit of Medicaid program prescription drug costs. [HB-1445]
Audit of Medicaid program prescription drug costs. Amends the requirements for a physician to provide office based opioid treatment. Provides that the attorney general may issue a request for proposal to audit the prescription drug programs within the state employee health plan and the Medicaid program. Provides that the attorney general may evaluate and determine whether to include specified metrics in the request for proposal. Provides that the audit look back period must be the previous five state fiscal years. Provides that the results of the
(continued...)
Sponsored by: Sen. Mike Bohacek
Public Law 233 on 05/04/2023
Spread the world
Indiana 2023 Regular Session
Health matters. [HB-1462]
Health matters. Amends the requirements for a physician to provide office based opioid treatment. Requires an emergency department to annually submit to the Indiana department of health a substance use disorder treatment plan (plan) to initiate interventions with patients who have a substance use related emergency department visit. Requires the plan to provide an overall analysis and evaluation of the emergency department's ability to implement specified provisions. Provides that the services provided to a patient under a substance use disorder
(continued...)
Sponsored by: Sen. Vaneta Becker
Representative Mcnamara Added As Coauthor on 04/04/2023
Spread the world
Indiana 2023 Regular Session
Toxicology screening for xylazine. [HB-1286]
Toxicology screening for xylazine. Provides that, if the coroner reasonably suspects the cause of the person's death to be accidental or intentional overdose of an opioid or if the person was administered an overdose intervention drug prior to death and was unresponsive to the overdose intervention drug, the coroner shall test certain bodily fluids to determine whether the bodily fluid contained any amount, including a trace amount, of xylazine at the time of the person's death.
Sponsored by: Sen. Greg Taylor
Public Law 71 on 04/20/2023
Spread the world
Indiana 2023 Regular Session
Opioid settlement. [HB-1208]
Opioid settlement. Specifies that the distribution of funds from an opioid litigation settlement is subject to a bankruptcy court order or bankruptcy settlement. Provides that an annual distribution of less than $5,000 payable to a city or town pursuant to an opioid litigation settlement agreement must be paid instead to the county. (Under current law, the threshold is $1,000.) Specifies that amounts owed by the state for attorney's fees and costs incurred in connection with opioid litigation must be deducted from the opioid settlement distribution
(continued...)
Sponsored by: Rep. Philip GiaQuinta
First Reading: Referred To Committee On Appropriations on 02/27/2023
Spread the world
Indiana 2023 Regular Session
Medical and adult use cannabis. [HB-1039]
Medical and adult use cannabis. After marijuana is removed as a federal schedule I controlled substance, permits the use of cannabis by: (1) a person at least 21 years of age; and (2) a person with a serious medical condition as determined by the person's physician. Establishes the adult use cannabis excise tax, and requires a retailer to transfer the tax to the department of state revenue for deposit in the state general fund. Exempts veterans from payment of the sales tax on medical or adult use cannabis. Establishes a cannabis program to permit
(continued...)
Sponsored by: Rep. Doug Miller
Authored By Representative Teshka on 01/09/2023
Spread the world
Indiana 2023 Regular Session
Prescription drug donation repositories. [HB-1017]
Prescription drug donation repositories. Establishes the prescription drug donation repository program (program). Establishes a fee on each person who is issued a license, registration, or certificate by a health profession board for the program. Allows a person to donate prescription drugs and supplies to a central repository or local repository for use by an individual who is an eligible recipient. Excludes abortion inducing drugs and controlled substances from the program. Allows an eligible entity to apply to participate as a local repository
(continued...)
Sponsored by: Sen. Lonnie Randolph
Public Law 208 on 05/04/2023
Spread the world
Kentucky 2023 Regular Session
AN ACT relating to the regulation of cannabis and making an appropriation therefor. [SB-51]
Establish KRS Chapter 245, relating to cannabis, to administer its cultivation, processing, transportation, sale, use, taxation, and licensing; define terms; establish the Cannabis Control Board and its membership, procedures, powers, and duties; direct the board to promulgate administrative regulations for the administration and enforcement of the chapter; set up advisory committees appointed by the board; create the Department of Cannabis Control within the Public Protection Cabinet for the oversight of cannabis operations and to provide administrative
(continued...)
Sponsored by: Sen. David Yates
To Appropriations & Revenue (s) on 03/01/2023
Spread the world
Kentucky 2023 Regular Session
AN ACT relating to the establishment of emergency insulin programs and declaring an emergency. [HB-141]
Create various new sections of KRS Chapter 211 to define terms; establish the Urgent-Need Insulin Program and the Continuing Access to Insulin Program; establish eligibility guidelines; establish the application process; establish the process by which insulin is dispensed to eligible individuals; establish the responsibilities of insulin manufacturers; establish the responsibilities of the Kentucky Board of Pharmacy for administering the program; require manufacturers to annually report certain information to the board; require the board to report
(continued...)
Sponsored by: Rep. Danny Bentley
Introduced In House on 01/06/2023
Spread the world
Kentucky 2023 Regular Session
AN ACT relating to immunization exceptions. [HB-110]
Amend KRS 214.036 to add conscientiously held beliefs to the list of exceptions to immunization requirements.
Sponsored by: Rep. Jim Gooch
Introduced In House on 01/05/2023
Spread the world
Kentucky 2023 Regular Session
AN ACT relating to medicinal cannabis and making an appropriation therefor. [HB-107]
Create new sections of KRS Chapter 218A to define terms and establish a medicinal cannabis program; amend KRS 342.815 to establish that the Employer’s Mutual Insurance Authority shall not be required to provide coverage to an employer if doing so would subject the authority to a violation of state or federal law; amend KRS 139.470 to exempt the sale of medical cannabis from the state sales tax; amend KRS 138.870 to exempt medicinal cannabis from the excise tax on controlled substances; amend KRS 216B.402 to require hospital emergency departments
(continued...)
Sponsored by: Rep. Derrick Graham
To Appropriations & Revenue (h) on 02/23/2023
Spread the world
Kentucky 2023 Regular Session
AN ACT relating to medicinal cannabis. [SB-47]
Create new sections of KRS Chapter 218A to define terms and establish a medicinal cannabis program; amend KRS 342.815 to establish that the Employer’s Mutual Insurance Authority shall not be required to provide coverage to an employer if doing so would subject the authority to a violation of state or federal law; amend KRS 216B.402 to require hospital emergency departments to report cases of cannabinoid hyperemesis syndrome to the Department of Alcoholic Beverage and Cannabis Control; amend KRS 218A.010, 218A.1421, 218A.1422, 218A.1423, and 218A.500
(continued...)
Sponsored by: Sen. Gerald Neal
Signed By Governor (acts Ch. 146) on 03/31/2023
Spread the world
Kentucky 2023 Regular Session
AN ACT relating to pharmacists. [SB-37]
Amend KRS 315.0351 to add that pharmacist in charge of an out-of-state pharmacy is required to be licensed in the Commonwealth.
Sponsored by: Sen. Julie Adams
Delivered To Secretary Of State (acts Ch. 136) on 03/29/2023
Spread the world
Kentucky 2023 Regular Session
AN ACT relating to controlled substances. [HB-98]
Create new sections of KRS Chapter 211 to establish a program for harm reduction centers; amend possession of controlled substance statutes to reduce penalty; amend KRS 218A.275 to provide for referrals to treatment for persons charged with possession of controlled substances; amend KRS 218A.500 to decriminalize possession of items to test, store, or consume controlled substances; repeal KRS 218A.14151, 218A.1450, 218A.1451, 218A.1452, and 218A.276.
Sponsored by: Rep. George Brown
Introduced In House on 01/04/2023
Spread the world
Kentucky 2023 Regular Session
AN ACT relating to the Kentucky Board of Pharmacy. [SB-36]
Amend KRS 315.150, relating to the Board of Pharmacy, to change the membership qualifications and appointments; make board appointments subject to confirmation by the Senate; add noncodified sections to set board appointments and terms.
Sponsored by: Sen. Julie Adams
Withdrawn on 02/08/2023
Spread the world
Kentucky 2023 Regular Session
AN ACT relating to coverage for injectable epinephrine devices. [HB-68]
Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to cover injectable epinephrine devices for persons 18 years of age and under; provide that the coverage shall not be subject to cost-sharing requirements; amend KRS 205.522, 205.6485, 164.2871, and 18A.225 to require Medicaid, KCHIP, self-insured employer group health plans offered by the governing board of a state postsecondary education institution, and the state employee health plan to comply with the 18-and-under injectable epinephrine device coverage requirement;
(continued...)
Sponsored by: Rep. George Brown
Introduced In House on 01/03/2023